Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Use of micropulse laser in patients with diabetic macular edema at the department of ophthalmology, university hospital Hradec Králové

Veselá Š., Hejsek L., Stepanov A., Dusová J., Marák J., Jirásková N., Studnička J.

Language English Country Czech Republic

Document type Case Reports

Introduction: Diabetic macular edema (DME) is the most frequent cause of decreased vision in patiens with diabetes type 2. DME is caused by increased permeability of macular capillaries. The aim of our study was to retrospectively evaluate the results of micropulse laser treatment, 577 nm wavelength, in pacients with DME with follow-up three months and one year. Methods: The retrospective trial with one year follow-up includes 63 eyes of 37 patients with diabetic macular edema treated from September 2015 to January 2017. Most patients had diabetes type 2 (34 patients), 3 patients had diabetes type 1. Diffuse DME was diagnosed in 54 eyes, focal DME in 9 eyes. Most of the patients (42 eyes) suffered from non proliferative diabetic retinopathy, 21 eyes showed signs of proliferative retinopathy. DME lasted on average for 29 months before initiating with micropulse laser (median 21 months). On average 1,56 laser visits were needed for the treatment of 1 eye, usually in 3 months interval. Photocoagulation of macula was performed in all patients by micropulse laser, 577 nm wavelenght/IQ 577TM IRIDEX). We used 5 % duty cycle. The average glycated hemoglobin in the group was 66,8 mmol/mol, maximal 100 mmol/mol. Estimated data were statistically evaluated by Friedman and Dunn´s test. Results: At the end of 1 year period we found out improvement in BCVA (increase of at least 5 letters of ETDRS charts) in 20 eyes, 25 eyes showed stabilisation of BCVA (alltogether 71 % of the group), in 18 eyes we found out decrease of BCVA of more than 5 letters of ETDRS charts. On average we estimated decrease of visual acuity from 62 to 61,1 letters (p > 0,05). After one year we estimated 63 μm CRT decrease on average, from 442 μm to 379 μm (p= 0,0124). Conclusion: In our group of DME patiens treated by micropulse laser we have estimated BCVA stabilisation and signifiant improvement of macular edema in ¾ eyes, confirmed by OCT. We have estimated clinically significant decrease of macular edema in the whole group with one-year follow-up.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19000073
003      
CZ-PrNML
005      
20210602022144.0
007      
cr|cn|
008      
190104s2018 xr ac fs 000 0|eng||
009      
AR
024    0_
$a 10.31348/2018/1/2-2-2018 $2 doi
035    __
$a (PubMed)30441950
040    __
$a ABA008 $d ABA008 $e AACR2 $b cze
041    0_
$a eng
044    __
$a xr
100    1_
$a Veselá, Šárka $7 xx0228406 $u Department of Ophthalmology, University Hospital Hradec Králové
245    10
$a Use of micropulse laser in patients with diabetic macular edema at the department of ophthalmology, university hospital Hradec Králové / $c Veselá Š., Hejsek L., Stepanov A., Dusová J., Marák J., Jirásková N., Studnička J.
520    3_
$a Introduction: Diabetic macular edema (DME) is the most frequent cause of decreased vision in patiens with diabetes type 2. DME is caused by increased permeability of macular capillaries. The aim of our study was to retrospectively evaluate the results of micropulse laser treatment, 577 nm wavelength, in pacients with DME with follow-up three months and one year. Methods: The retrospective trial with one year follow-up includes 63 eyes of 37 patients with diabetic macular edema treated from September 2015 to January 2017. Most patients had diabetes type 2 (34 patients), 3 patients had diabetes type 1. Diffuse DME was diagnosed in 54 eyes, focal DME in 9 eyes. Most of the patients (42 eyes) suffered from non proliferative diabetic retinopathy, 21 eyes showed signs of proliferative retinopathy. DME lasted on average for 29 months before initiating with micropulse laser (median 21 months). On average 1,56 laser visits were needed for the treatment of 1 eye, usually in 3 months interval. Photocoagulation of macula was performed in all patients by micropulse laser, 577 nm wavelenght/IQ 577TM IRIDEX). We used 5 % duty cycle. The average glycated hemoglobin in the group was 66,8 mmol/mol, maximal 100 mmol/mol. Estimated data were statistically evaluated by Friedman and Dunn´s test. Results: At the end of 1 year period we found out improvement in BCVA (increase of at least 5 letters of ETDRS charts) in 20 eyes, 25 eyes showed stabilisation of BCVA (alltogether 71 % of the group), in 18 eyes we found out decrease of BCVA of more than 5 letters of ETDRS charts. On average we estimated decrease of visual acuity from 62 to 61,1 letters (p > 0,05). After one year we estimated 63 μm CRT decrease on average, from 442 μm to 379 μm (p= 0,0124). Conclusion: In our group of DME patiens treated by micropulse laser we have estimated BCVA stabilisation and signifiant improvement of macular edema in ¾ eyes, confirmed by OCT. We have estimated clinically significant decrease of macular edema in the whole group with one-year follow-up.
650    _2
$a lidé $7 D006801
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a výsledek terapie $7 D016896
650    12
$a komplikace diabetu $7 D048909
650    _2
$a diabetes mellitus 2. typu $x komplikace $7 D003924
650    _2
$a diabetes mellitus 1. typu $x komplikace $7 D003922
650    12
$a makulární edém $x diagnostické zobrazování $x etiologie $x terapie $7 D008269
650    12
$a laserová terapie $x metody $7 D053685
650    _2
$a optická koherentní tomografie $x metody $7 D041623
650    _2
$a laserová koagulace $x metody $x přístrojové vybavení $7 D017075
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a diabetická retinopatie $x diagnostické zobrazování $x komplikace $7 D003930
650    _2
$a glykovaný hemoglobin $x analýza $7 D006442
650    _2
$a statistika jako téma $7 D013223
650    _2
$a zraková ostrost $x účinky záření $7 D014792
650    _2
$a retina $x diagnostické zobrazování $7 D012160
650    _2
$a fundus oculi $7 D005654
650    _2
$a dávka záření $7 D011829
653    00
$a centrální retinální tloušťka
653    00
$a mikropulzní laser
653    00
$a zisk písmen
655    _2
$a kazuistiky $7 D002363
700    1_
$a Hejsek, Libor, $d 1977- $7 mzk2007408327 $u Department of Ophthalmology, University Hospital Hradec Králové
700    1_
$a Stěpanov, Alexandr $u Department of Ophthalmology, University Hospital Hradec Králové $7 xx0227507
700    1_
$a Dusová, Jaroslava, $u Department of Ophthalmology, University Hospital Hradec Králové $d 1959- $7 xx0063648
700    1_
$a Marák, Jan $u Department of Ophthalmology, University Hospital Hradec Králové $7 xx0159941
700    1_
$a Jirásková, Naďa, $u Department of Ophthalmology, University Hospital Hradec Králové $d 1965- $7 mzk2007395044
700    1_
$a Studnička, Jan $u Department of Ophthalmology, University Hospital Hradec Králové $7 jx20090420023
773    0_
$t Czech and Slovak Ophthalmology $g Roč. 5, č. 2 (2018), s. 53-58 $w MED00194413
856    41
$u http://www.cs-ophthalmology.cz/en/journal/2018/2/2 $y plný text volně přístupný
910    __
$a ABA008 $b online $y p $z 0
990    __
$a 20190104132740 $b ABA008
991    __
$a 20210602022143 $b ABA008
999    __
$a ok $b bmc $g 1363066 $s 1038185
BAS    __
$a 3 $a 4
BMC    __
$a 2018 $b 5 $c 2 $d 53-58 $m Czech and Slovak Ophthalmology $x MED00194413
LZP    __
$c NLK189 $d 20210531 $a NLK 2019-01/pk

Find record

Citation metrics

Loading data ...